查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1835241

心臟帮浦设备市场按设备类别、最终用户、销售管道和应用划分－2025-2032 年全球预测

Heart Pump Device Market by Device Category, End User, Sales Channel, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年心臟帮浦设备市场将成长至 186.4 亿美元，复合年增长率为 16.39%。

主要市场统计数据
基准年2024年 55.3亿美元
预计2025年 64.6亿美元
预测年份：2032年 186.4亿美元
复合年增长率（%） 16.39%

全面的策略介绍，概述了影响机械循环支援的临床要求、技术进步和机构压力

报告首先清楚阐述了在日益增长的临床需求和不断发展的技术生态系统中，为何心臟帮浦设备值得策略重点关注。机械循环支援的进步正在改变患者的治疗路径，使更多患者能够延长生命并改善功能状态，同时也对设备的安全性、耐用性以及与数位医疗平台的整合提出了新的要求。临床医生、医院管理人员和设备製造商正在应对一系列临床需求、监管审查和供应链复杂性，这些因素将决定他们近期的营运格局。

虽然全人工心臟和辅助人工心臟等设备的临床证据已得到充分证实，但微型化、生物相容性材料、感测器控制和远端监控等技术创新正在重塑现代市场。这些技术进步正在扩大适应症，使其能够在门诊病人和门诊手术中心使用。此外，付款人期望与证据生成之间的相互作用促使製造商优先考虑真实世界的性能数据和基于价值的治疗结果。因此，将创新转化为持久的商业性成功需要整合临床路径、报销策略和生产可扩展性的策略规划。

因此，相关人员应该采取以患者和系统为中心的观点，预测护理地点的变化、设备和软体生态系统的融合以及对植入后追踪的不断提高的期望。本介绍透过强调影响心臟帮浦设备生态系统所有参与者策略选择的核心力量来为以下章节建立背景：临床需求、技术进步、监管动态和供应链压力。

深入检验技术创新、不断发展的护理服务以及重新定义心臟泵治疗竞争优势的证据需求

在技​​术突破、医疗服务模式不断演变以及对长期疗效日益关注等诸多因素的共同推动下，心臟帮浦领域正在经历重大变革。微创植入技术和更紧凑的帮浦设计正在扩大患者群体，同时降低手术全期风险，从而推动从单纯住院治疗转向门诊和门诊治疗。同时，嵌入式感测器和远端监控平台的普及使得持续的生理监测成为可能，有助于早期疗育，并降低再入院率——这是医疗保健系统的关键绩效指标。

同样，将目标疗法发展成为可持续的治疗途径，而非移植前的过渡，也至关重要。随着器械耐用性的提高和生物相容性的进步降低併发症率，即使对于不适合移植的患者，临床医生也越来越有可能考虑机械支持。这种转变推动了对强大的长期管理模式的需求，包括远端远端检测、结构化的抗凝血门诊和综合復健计划。监管趋势正在不断调整，以适应器械的渐进式更新和软体主导的功能，要求製造商将开发蓝图与上市后监管义务和真实世界证据的生成相结合。

同时，相关人员对医疗总成本的期望正促使设备製造商展现超越设备性能的价值。医院和付款方越来越要求提供将设备使用与缩短住院时间、降低再入院率以及降低后续成本相关联的数据。因此，策略差异化取决于能否提供临床有效性以及显着的健康经济效益。总而言之，这些变革正在重新定义竞争优势，使其成为令人信服的临床结果、可靠的证据生成以及与不断发展的护理路径无缝整合的交汇点。

深入评估近期美国关税行动如何重塑心臟帮浦设备价值链的供应链、筹资策略和商业性方法

美国在当前政策週期内征收和调整的关税，对心臟泵设备生态系统产生了多层次的影响，影响了采购决策、供应商关係和成本结构，但并未统一改变临床应用的动态。重要的是，针对关键子部件和原材料的关税正迫使製造商重新评估供应商多元化，加快替代供应商的资格审查，并考虑透过合约对冲来保护净利率。对于製造地集中在海外的公司来说，这些关税制度将促使他们考虑近岸外包、关键子组件的垂直整合或策略性库存缓衝，以维持供应的连续性。

这些贸易摩擦也将对分销策略和服务模式产生下游影响。医院和门诊中心的采购定价可能会逐步调整，进而影响资本采购週期和治疗方法的比较评估。为了保持采用势头，医疗设备製造商正在实施配套服务和延长保固期，以吸收部分买方的成本波动，同时寻求契约製造。

医疗器材和耗材价格持续上涨，可能促使人们重新审视报销途径和使用标准。因此，要应对关税的影响，需要采取多管齐下的应对措施，包括增强供应链韧性、优化定价策略、积极主动地与相关人员沟通，以及有针对性地投资于製造敏捷性。总体而言，美国在此期间的关税累积影响促使整个心臟泵设备价值链的采购、生产和销售策略重新平衡。

综合策略细分，以定义跨装置类别、护理环境、通路和应用的差异化临床、商业和製造优先事项

細項分析揭示了不同设备类别、护理环境、销售管道和临床应用之间的差异化策略重点，从而创造了多种成长和专业化途径。在设备类别中，全人工心臟和辅助人工心臟之间有明显差异。后者进一步细分为双心室、左心室和右心室辅助装置，每种装置都有不同的工程复杂性、临床工作流程和售后需求。这种子类别划分影响製造复杂性和售后市场需求，与左心室系统相比，右侧辅助装置通常具有不同的血流动力学控制和尺寸限制。

终端使用者细分揭示了门诊手术中心和医院之间不同的采购和临床应用动态。随着设备配置的演变和手术全期路径的简化，门诊手术中心逐渐成为低风险手术的中心。销售管道的差异——直销与代理商主导——决定了销售资源的分配和客户参与策略。直销通常能够提供更深入的临床培训和更紧密的服务合约整合，而代理销售则能够为缺乏完整销售基础设施的公司提供更广泛的地域覆盖和通路整合。

基于应用的差异化进一步细化了机会集。移植前桥接用例需要与移植中心网路合作，并且通常涉及复杂的患者选择和短期管理通讯协定。目标疗法细分为成人和儿科，强调设备的长期可靠性、患者支持生态系统和生命週期管理计划。儿科目标疗法增加了与生长适应和长期生物相容性相关的监管和设计考量。这些细分领域相结合，使製造商和医疗保健提供者能够优先投资于与其能力和市场愿景在策略上最契合的产品设计、临床教育和服务模式。

细緻的区域分析考虑了美洲、中东和非洲以及亚太地区不同的监管、报销和医疗保健服务要求

亚太地区、欧洲以及中东和非洲地区各自呈现不同的机会和法规环境，对商业化和业务策略产生重大影响。在美洲，成熟的三级医疗网路和先进的报销机制推动了尖端机械循环支援解决方案的采用，从而推动了市场需求。然而，采购週期和医院预算限制仍然需要令人信服的价值主张和可靠的临床证据来支持资本投资决策。

中东和非洲地区在监管途径和医疗保健系统资金筹措表现出差异性，需要製定量身定制的打入市场策略。在西方市场，成熟的监管协调机制和专业的心臟中心有助于精准投放和收集上市后数据，而政府主导的现代化项目和不断扩张的私人医院则为一些中东市场提供了机会。在整个非洲，基础设施欠发达和专科医生能力有限将导致采用时间更长。

亚太地区呈现出双重特征：高度发展的市场和快速发展的医疗保健生态系统。在不断增长的国内製造能力和战略伙伴关係关係的支持下，该地区的高所得市场相对较快地采用了创新设备功能和数位化整合。相反，新兴市场则优先考虑可负担性、本地交付和临床培训。在这种环境下，成功通常取决于灵活的定价策略、本地化的临床教育计画以及能够支援分散式医疗服务的经销商网路。这些区域差异共同要求制定量身定制的上市模式，这些模式必须尊重当地的管理体制、报销现实情况和临床能力，同时还要建立一个可扩展的营运框架，以适应需求和基础设施的发展。

前瞻性竞争评估重点在于产品创新、临床证据生态系统和生命週期服务如何决定机械循环支援领域的领导地位

心臟泵设备生态系统的竞争力日益取决于其将临床证据、生产规模和卓越的售后服务整合成一致价值提案的能力。领先的公司持续投资于迭代设备改进、感测器监控和远端系统管理平台，以减轻临床医生负担并改善患者治疗效果。同时，新参与企业正在利用颠覆性材料科学、更小的外形规格和软体主导的控制架构，挑战关于设备设计和患者选择的传统假设。

製造商之间的策略行动包括横向和纵向伙伴关係、有针对性的收购以确保组件产能，以及与三级医疗中心开展合作临床项目以加速证据产生。对于那些寻求扩大生产规模并保持灵活性以适应不断变化的关税和监管要求的公司而言，合约製造商和专业供应商已成为重要的策略合作伙伴。智慧财产权组合和监管备案是关键的差异化因素，尤其是在新型血流动力学控制演算法或生物相容性材料具有临床或营运优势的情况下。

服务和生命週期管理能力是竞争的关键领域。能够将设备硬体与强大的培训、远端监控、预测性维护和结果报告功能相结合的公司拥有更强大的商业关係和更广泛的定价策略。最后，儿科专业技能和针对较小患者群体的个人化证据获取是利基领域，有针对性的投资可以带来可持续的竞争优势。总体而言，产品差异化、证据产生、供应链弹性和卓越服务的结合将决定哪些公司将在高危急症护理医院市场和新兴门诊市场中占据领先地位。

以下是领导者可以采取的一些策略建议，以协调临床证据产生、供应链弹性和服务创新，从而加速采用并保持竞争优势：

产业领导者应采取投资组合策略，在短期商业化投资与降低风险、提升临床价值的持久能力之间取得平衡。首先，优先产生可操作的临床证据，这些证据不仅能证明设备性能，还能证明其降低下游利用率和改善病患报告结果的能力。将远端监控资料和标准化结果指标纳入付款人对话，可以增强报销地位并缩短采购决策週期。

第二，透过多元化供应商、确定关键零件的二级资讯来源以及考虑高风险次组件的本地组装或近岸外包来增强供应链的韧性。这些措施将减轻关税的影响，并支持快速应对监管和疫情带来的干扰。第三，设计反映最终用户实际状况的商业模式。这意味着要在销售量，同时在新兴和成本敏感型市场建立经销商伙伴关係并提供灵活的定价。

第四，扩展服务范围，包括远端患者管理、预测性维护和以结果为导向的培训项目，以创造经常性收益来源并深化客户关係。第五，制定针对小儿科市场的策略，该市场临床差异化和竞争有限，在确保设备架构能够实现成长和长期生物相容性的同时，证明高端定位的合理性。最后，积极与监管机构和付款方合作，共同开发一个上市后监测框架，在保障病人安全的同时支持迭代改进。透过同时实施这些建议，企业可以将技术创新转化为永续的商业性优势和系统级价值。

采用严格的混合方法研究途径，整合临床医师访谈、监管分析、供应链映射和证据三角测量，以检验策略结论

本分析的基础研究采用混合方法，整合了主要相关人员访谈、临床文献综述、监管申报分析和供应链图谱，以确保对研究结果进行三角比较。主要访谈对象包括心臟外科医师、心臟衰竭循环系统、采购经理、製造主管和临床试验负责人等多位专家，旨在了解医疗保健机构的营运现状和策略重点。这些定性见解辅以同行评审临床研究、註册数据和特定器械上市后报告的系统性回顾，从而将器械性能叙述与已发表的证据联繫起来。

透过审查公告、指导文件和付款人政策声明，分析了监管和报销格局，从而能够映射各主要司法管辖区的核准和申请考虑。供应链韧性评估结合了供应商网路分析、贸易流量数据和公开讯息，以识别瓶颈、单一来源依赖以及潜在的缓解措施，例如替代供应商和本地生产。透过分析专利格局、产品发布追踪和公司公告，评估了竞争格局，以捕捉合作伙伴关係、授权协议和製造投资等策略倡议。

在整个研究週期中，研究结果经过专家反覆检验，并与多个资讯来源进行最后覆核，以减少偏差并确保准确性。公共资料中的缺失部分透过针对性的专家访谈得以具体化。这种方法最终得出了全面的、基于证据的结论，既反映了临床现实，也反映了商业性需求。

简洁的结论综合了技术创新、证据生成和操作弹性如何融合以决定机械循环支援的成功。

摘要，心臟帮浦设备产业正处于曲折点，临床创新、医疗服务转型和营运韧性必须齐头并进，才能实现更广泛的应用并造福患者。虽然技术进步正在扩大适应症并带来新的照护环境，但成功的商业化将取决于能否展现长期价值、管理复杂的供应链，以及整合服务以支持患者和医疗服务提供者的全程照护。同时，细分洞察凸显了产品需求和上市策略的明显差异。

综上所述，这些动态表明，那些致力于产生可操作证据、建立适应性製造模式并提供卓越生命週期服务的组织将最有可能主导。透过专注于决策者关注的临床和经济因素，并加强营运基础以减轻外部衝击，相关人员可以将创新转化为改善的患者治疗效果和可持续的商业性回报。本文的结论为规划和有针对性地执行产品开发、上市和上市后支援的后续步骤提供了策略基础。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 越来越多地采用具有无线充电功能的完全植入式左心室辅助装置
  • 越来越多地使用远端监控平台来追踪心臟帮浦患者的即时血流动力学数据
  • 磁浮叶轮技术开发，减少机械循环支持过程中的血液损伤
  • 扩大左心室补助人工心臟的适应症，包括中度心臟衰竭和门诊病人
  • 整合人工智慧演算法，对心肺支援设备效能和病患结果进行预测分析
  • 经皮右心室辅助系统的出现，为右心臟衰竭提供微创支持
  • 我们专注于生物相容性表面涂层，以最大限度地减少血栓症形成并减少长期抗凝血治疗的需要。
  • 设备製造商和远端医疗提供者之间的合作，以加强远距患者管理

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章：心臟帮浦设备市场（依设备类别）

  • 全人工心臟
  • 心室辅助装置
    • 双心室辅助装置
    • 左心室补助人工心臟
    • 右心室辅助装置

第 9 章：心臟帮浦设备市场（依最终用户划分）

  • 门诊手术中心
  • 医院

第 10 章心臟帮浦设备市场依销售管道

  • 直销
  • 经销商销售

第11章心臟帮浦设备市场（依应用）

  • 移植桥樑
  • 目的地疗法
    • 成人
    • 孩子们

第十二章心臟帮浦设备市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 13 章：心臟帮浦设备市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章心臟帮浦设备市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Medtronic plc
    • Abiomed, Inc.
    • LivaNova PLC
    • Getinge AB
    • Terumo Corporation
    • B. Braun Melsungen AG
    • SynCardia Systems, LLC
    • Carmat SA
    • Berlin Heart GmbH
Product Code: MRR-437E9896A563

The Heart Pump Device Market is projected to grow by USD 18.64 billion at a CAGR of 16.39% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.53 billion
Estimated Year [2025] USD 6.46 billion
Forecast Year [2032] USD 18.64 billion
CAGR (%) 16.39%

A comprehensive strategic introduction outlining the clinical imperatives, technological advances, and systemic pressures reshaping mechanical circulatory support delivery

This report opens with a clear framing of why heart pump devices warrant concentrated strategic attention amid intensifying clinical demand and evolving technology ecosystems. Advances in mechanical circulatory support have shifted patient pathways, enabling more patients to live longer and with improved functional status, while simultaneously creating new imperatives for device safety, durability, and integration with digital care platforms. Clinicians, hospital administrators, and device manufacturers are navigating a confluence of clinical need, regulatory scrutiny, and supply chain complexity that together define the near-term operational landscape.

While the clinical rationale for devices such as total artificial hearts and ventricular assist devices is well established, the contemporary market is being reshaped by innovations in miniaturization, biocompatible materials, sensor-enabled controls, and telemonitoring. These technological improvements are extending indications and enabling greater use in outpatient and ambulatory surgical center settings. Moreover, the interplay between payer expectations and evidence generation is driving manufacturers to prioritize real-world performance data and value-based outcomes. Consequently, strategic planning must integrate clinical pathways, reimbursement strategies, and manufacturing scalability to convert innovation into durable commercial success.

As a result, stakeholders should adopt a patient- and system-centered view that anticipates shifting treatment locations, converging device and software ecosystems, and heightened expectations for post-implant follow-up. This introduction establishes the context for subsequent sections by highlighting the core forces-clinical need, technological progress, regulatory dynamics, and supply chain pressures-that together shape strategic choices for all participants in the heart pump device ecosystem.

An incisive examination of technological innovation, care delivery evolution, and evidence demands that are redefining competitive advantage in heart pump therapy

The landscape for heart pump devices is undergoing transformative shifts driven by a combination of technological breakthroughs, evolving care delivery models, and increasing emphasis on long-term outcomes. Minimally invasive implantation techniques and more compact pump architectures are broadening candidate populations while reducing perioperative risk, which in turn supports a transition from exclusively inpatient procedures toward ambulatory and outpatient settings. Concurrently, the proliferation of embedded sensors and remote monitoring platforms is enabling continuous physiologic surveillance, facilitating early intervention and reducing readmission rates, which are critical performance indicators for health systems.

Equally consequential is the maturation of destination therapy as a sustained treatment pathway rather than a bridge to transplant. As device durability improves and biocompatibility advances lower complication rates, clinicians are more likely to consider mechanical support for patients who are not transplant candidates. This shift increases the need for robust long-term management models, including remote telemetry, structured anticoagulation clinics, and integrated rehabilitation programs. Regulatory pathways are adapting to accommodate incremental device updates and software-driven features, requiring manufacturers to align development roadmaps with post-market surveillance obligations and real-world evidence generation.

In parallel, stakeholder expectations around total cost of care are prompting device makers to demonstrate value beyond device performance. Hospitals and payers increasingly demand data that correlate device use with reductions in length of stay, rehospitalizations, and downstream costs. Therefore, strategic differentiation will hinge on the ability to deliver clinical efficacy alongside demonstrable health-economic benefits. Taken together, these transformative shifts redefine competitive advantage as the intersection of compelling clinical outcomes, robust evidence generation, and seamless integration into evolving care pathways.

A detailed assessment of how recent United States tariff dynamics are reshaping supply chains, sourcing strategies, and commercial approaches across the heart pump device value chain

The imposition and adjustment of tariffs in the United States during the current policy cycle have imposed layered effects on the heart pump device ecosystem, influencing component sourcing decisions, supplier relationships, and cost structures without uniformly altering clinical adoption dynamics. Importantly, tariffs that target key subcomponents or raw materials pressure manufacturers to reassess supplier diversification, accelerate qualification of alternate vendors, and consider contractual hedges that protect margins. For companies with concentrated offshore manufacturing footprints, such tariff regimes stimulate deliberations about nearshoring, vertical integration of critical subassemblies, or strategic inventory buffering to maintain supply continuity.

These trade-related frictions also have downstream implications for distribution strategies and service models. Hospitals and ambulatory centers may experience phased adjustments in procurement pricing that influence capital purchase cycles and comparative evaluations across therapeutic options. To preserve adoption momentum, device companies are increasingly implementing bundled-service propositions and extended warranties that absorb some cost volatility for buyers, while simultaneously seeking operational efficiencies in manufacturing and logistics. Furthermore, tariffs can complicate collaborative arrangements with contract manufacturers and foreign research partners by introducing administrative and compliance overhead that lengthens time-to-market for incremental product updates.

Regulatory and payer stakeholders react to cost dynamics as well; sustained increases in equipment and consumable prices can prompt closer scrutiny of reimbursement pathways and utilization criteria. Consequently, navigating tariff impacts requires a multifaceted response that combines supply-chain resilience, pricing strategy refinement, proactive stakeholder communication, and targeted investments in manufacturing agility. In sum, the cumulative tariff effects in the United States during this period have catalyzed a rebalancing of sourcing, production, and commercial tactics across the heart pump device value chain.

A strategic segmentation synthesis that clarifies differentiated clinical, commercial, and manufacturing priorities across device categories, care settings, channels, and applications

Segmentation analysis reveals differentiated strategic priorities across device categories, care settings, sales channels, and clinical applications that together create multiple routes to growth and specialization. Within device category, there is a clear distinction between total artificial hearts and ventricular assist devices; the latter further segments into biventricular, left ventricular, and right ventricular assist devices, each with distinct engineering complexity, clinical workflows, and follow-on service demands. These intra-category distinctions influence manufacturing complexity and aftermarket needs, with right-sided support typically featuring different hemodynamic controls and size constraints compared with left ventricular systems.

End-user segmentation highlights divergent procurement and clinical adoption dynamics between ambulatory surgical centers and hospitals. Hospitals remain the primary locus for advanced implantations due to their intensive care capabilities and multidisciplinary teams, whereas ambulatory surgical centers represent a growing locus for lower-risk procedures as device profiles evolve and perioperative pathways become more streamlined. Sales channel differentiation between direct sales and distributor-led models shapes commercial resource allocation and customer engagement tactics. Direct sales often enable deeper clinical training and tighter integration of service contracts, while distributor sales can provide broader geographic reach and channel moderation for companies without a full sales infrastructure.

Application-based distinctions further refine opportunity sets. The bridge-to-transplant use case requires alignment with transplant center networks and often entails complex patient selection and short-term management protocols. Destination therapy, which is subdivided into adult and pediatric populations, places a premium on long-term device reliability, patient support ecosystems, and life-cycle management programs. Pediatric destination therapy introduces additional regulatory and design considerations related to growth accommodation and long-term biocompatibility. By synthesizing these segmentation lenses, manufacturers and providers can prioritize investments in product design, clinical education, and service models that correspond to the highest strategic fit for their capabilities and market aspirations.

A nuanced regional analysis describing differentiated regulatory, reimbursement, and care delivery imperatives across the Americas, Europe Middle East and Africa, and Asia Pacific

Regional dynamics offer varied opportunity sets and regulatory environments that materially influence commercialization and operational strategies across the Americas, Europe Middle East and Africa, and Asia Pacific. In the Americas, demand drivers are underpinned by established tertiary care networks and advanced reimbursement mechanisms that facilitate the adoption of cutting-edge mechanical circulatory support solutions; however, procurement cycles and hospital budget constraints still require compelling value narratives and robust clinical evidence to support capital investment decisions.

The Europe Middle East and Africa region exhibits heterogeneity in regulatory pathways and health system financing, which necessitates tailored market entry strategies. In Western European markets, established regulatory harmonization and specialized cardiac centers enable focused launches and post-market data collection, while certain Middle Eastern markets present opportunities through government-led modernization programs and private hospital expansion. Across Africa, nascent infrastructure and limited specialist capacity imply longer timelines for adoption, with opportunities often tied to capacity building, training partnerships, and phased technology transfer.

Asia Pacific presents a dual landscape of highly advanced markets alongside rapidly developing care ecosystems. High-income markets within the region adopt innovative device features and digital integration relatively quickly, supported by growing domestic manufacturing capabilities and strategic partnerships. Conversely, emerging markets prioritize affordability, local serviceability, and clinical training; success in these settings often hinges on adaptive pricing strategies, localized clinical education programs, and distributor networks that can support decentralized care delivery. Collectively, these regional distinctions require calibrated go-to-market models that respect local regulatory regimes, reimbursement realities, and clinical capacity, while allowing for scalable operational frameworks that can be adapted as demand and infrastructure evolve.

A forward-looking competitive assessment highlighting how product innovation, clinical evidence ecosystems, and lifecycle services determine leadership in mechanical circulatory support

Competitive dynamics in the heart pump device ecosystem are increasingly defined by the ability to integrate clinical evidence, manufacturing scale, and aftermarket service excellence into a coherent value proposition. Leading organizations continue to invest in iterative device improvements, sensor-enabled monitoring, and remote management platforms that reduce clinician burden and improve patient outcomes. Concurrently, emerging entrants are leveraging disruptive materials science, smaller form factors, and software-driven control architectures to challenge legacy assumptions about device design and patient selection.

Strategic behavior among manufacturers includes horizontal and vertical partnerships, targeted acquisitions to secure component capabilities, and collaborative clinical programs with tertiary centers to accelerate evidence generation. Contract manufacturers and specialist suppliers have become critical strategic partners for firms seeking to scale production while maintaining flexibility to adapt to evolving tariffs and regulatory requirements. Intellectual property portfolios and regulatory filings serve as key differentiators, particularly where novel hemodynamic control algorithms or biocompatible materials confer clinical or operational advantages.

Service and lifecycle management capabilities are a major competitive battleground. Organizations that can bundle device hardware with robust training, remote monitoring, predictive maintenance, and outcome reporting create stickier commercial relationships and more defensible pricing positions. Finally, access to specialized pediatric expertise and evidence tailored to smaller patient cohorts represents a niche where targeted investments can yield durable competitive advantage. Overall, the combination of product differentiation, evidence generation, supply chain resilience, and service excellence will determine which companies lead in both high-acuity hospital markets and emerging ambulatory settings.

Actionable strategic recommendations for leaders to align clinical evidence generation, supply chain resilience, and service innovation to accelerate adoption and sustain competitive advantage

Industry leaders should adopt a portfolio approach that balances near-term commercialization with investments in durable capabilities that reduce risk and increase clinical value. First, prioritize the generation of pragmatic clinical evidence that demonstrates not only device performance but also the capacity to reduce downstream utilization and improve patient-reported outcomes. Integrating remote monitoring data and standardized outcome metrics into payer conversations will strengthen reimbursement positioning and shorten procurement decision cycles.

Second, fortify supply chain resilience by diversifying supplier bases, qualifying secondary sources for critical components, and exploring localized assembly or nearshoring for high-risk subassemblies. These measures mitigate tariff exposure and support faster response to regulatory or pandemic-driven disruptions. Third, design commercial models that reflect the realities of the end-user landscape: invest in direct-sales capabilities and clinical education in high-volume tertiary centers, while building distributor partnerships and adaptive pricing for emerging and cost-sensitive markets.

Fourth, expand service offerings that encompass remote patient management, predictive maintenance, and outcome-focused training programs to create recurring revenue streams and deepen customer relationships. Fifth, pursue targeted pediatric strategies where clinical differentiation and limited competition can justify premium positioning, while ensuring device architectures account for growth and long-term biocompatibility. Finally, engage proactively with regulators and payers to co-develop post-market surveillance frameworks that support iterative improvement while maintaining patient safety. By executing these recommendations in parallel, companies can convert technological innovation into sustainable commercial advantage and system-level value.

A rigorous mixed-methods research approach integrating clinician interviews, regulatory analysis, supply chain mapping, and evidence triangulation to validate strategic conclusions

The research underpinning this analysis draws on a mixed-methods approach that integrates primary stakeholder interviews, clinical literature review, regulatory filing analysis, and supply chain mapping to ensure robust triangulation of findings. Primary interviews were conducted with a diverse set of experts, including cardiac surgeons, heart failure cardiologists, procurement directors, manufacturing executives, and clinical trialists, to capture both operational realities and strategic priorities across care settings. These qualitative insights were supplemented by a systematic review of peer-reviewed clinical studies, registry data, and device-specific post-market reports to ground device performance narratives in published evidence.

Regulatory and reimbursement landscapes were analyzed through a review of public filings, guidance documents, and payer policy statements, enabling the mapping of approval and coverage considerations across major jurisdictions. Supply chain resilience assessments incorporated supplier network analysis, trade flow data, and public disclosures to identify bottlenecks, single-source dependencies, and potential mitigants such as alternate vendors or localized production. Competitive dynamics were evaluated through patent landscaping, product launch tracking, and analysis of corporate announcements to understand strategic moves such as partnerships, licensing agreements, and manufacturing investments.

Throughout the research lifecycle, findings were iteratively validated with subject-matter experts and cross-checked against multiple information sources to reduce bias and ensure accuracy. Where gaps in public data existed, targeted expert elicitation provided contextual clarity. This methodology ensures that conclusions are grounded in a comprehensive evidence base that reflects both clinical realities and commercial imperatives.

A succinct conclusion that synthesizes how innovation, evidence generation, and operational resilience converge to determine success in mechanical circulatory support

In summary, the heart pump device sector stands at an inflection point where clinical innovation, care delivery transformation, and operational resilience must align to realize broader adoption and patient benefit. Technological progress is enabling expanded indications and new care settings, yet successful commercialization will depend on the capacity to demonstrate long-term value, manage complex supply chains, and integrate services that support patients and providers across the continuum of care. Tariff-induced pressures and regional heterogeneity underscore the importance of supply diversification and localized strategies, while segmentation insights highlight clear differences in product requirements and go-to-market tactics.

Collectively, these dynamics suggest that organizations which invest in pragmatic evidence generation, adaptive manufacturing models, and compelling lifecycle service offerings will be best positioned to lead. By focusing on both the clinical and economic narratives that matter to decision-makers, and by strengthening operational foundations to mitigate external shocks, stakeholders can convert innovation into improved patient outcomes and durable commercial returns. The conclusions drawn here provide a strategic foundation for next-step planning and targeted execution across product development, market entry, and post-market support.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of fully implantable left ventricular assist devices with wireless charging integration
  • 5.2. Increased use of remote monitoring platforms for real-time hemodynamic data tracking in heart pump patients
  • 5.3. Development of magnetically levitated impeller technology to reduce blood trauma in mechanical circulatory support
  • 5.4. Expansion of left ventricular assist device indications to moderate heart failure and ambulatory patient populations
  • 5.5. Integration of artificial intelligence algorithms for predictive analytics in ventricular assist device performance and patient outcomes
  • 5.6. Emerging percutaneous right ventricular assist systems enabling minimally invasive support for right heart failure
  • 5.7. Focus on biocompatible surface coatings to minimize thrombosis and reduce long-term anticoagulation requirements
  • 5.8. Collaborations between device manufacturers and telehealth providers to enhance remote patient management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Pump Device Market, by Device Category

  • 8.1. Total Artificial Heart
  • 8.2. Ventricular Assist Devices
    • 8.2.1. BiVentricular Assist Devices
    • 8.2.2. Left Ventricular Assist Devices
    • 8.2.3. Right Ventricular Assist Devices

9. Heart Pump Device Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Hospitals

10. Heart Pump Device Market, by Sales Channel

  • 10.1. Direct Sales
  • 10.2. Distributor Sales

11. Heart Pump Device Market, by Application

  • 11.1. Bridge To Transplant
  • 11.2. Destination Therapy
    • 11.2.1. Adult
    • 11.2.2. Pediatric

12. Heart Pump Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Heart Pump Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Heart Pump Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Abbott Laboratories
    • 15.3.2. Medtronic plc
    • 15.3.3. Abiomed, Inc.
    • 15.3.4. LivaNova PLC
    • 15.3.5. Getinge AB
    • 15.3.6. Terumo Corporation
    • 15.3.7. B. Braun Melsungen AG
    • 15.3.8. SynCardia Systems, LLC
    • 15.3.9. Carmat SA
    • 15.3.10. Berlin Heart GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART PUMP DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. HEART PUMP DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. HEART PUMP DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HEART PUMP DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HEART PUMP DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HEART PUMP DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 99. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 130. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 185. AFRICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 186. AFRICA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. ASEAN HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. ASEAN HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 225. GCC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GCC HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GCC HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 228. GCC HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 229. GCC HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 230. GCC HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 231. GCC HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. GCC HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. GCC HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. GCC HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. GCC HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. GCC HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. GCC HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 238. GCC HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 253. BRICS HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. BRICS HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. BRICS HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 256. BRICS HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 257. BRICS HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 258. BRICS HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 259. BRICS HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. BRICS HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. BRICS HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 262. BRICS HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 263. BRICS HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. BRICS HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 267. G7 HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. G7 HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. G7 HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 270. G7 HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 271. G7 HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 272. G7 HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 273. G7 HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. G7 HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. G7 HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. G7 HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 277. G7 HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. G7 HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. G7 HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 280. G7 HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 281. NATO HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. NATO HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. NATO HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 284. NATO HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 285. NATO HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 286. NATO HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 287. NATO HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. NATO HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. NATO HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 290. NATO HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 291. NATO HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. NATO HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. NATO HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 294. NATO HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL HEART PUMP DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 299. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 301. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED STATES HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 309. CANADA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 310. CANADA HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 311. CANADA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 312. CANADA HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 313. CANADA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. CANADA HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. CANADA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 316. CANADA HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 317. CANADA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. CANADA HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. CANADA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 320. CANADA HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 321. MEXICO HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 322. MEXICO HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 323. MEXICO HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 324. MEXICO HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2025-2032 (USD MILLION)
  • TABLE 325. MEXICO HEART PUMP DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. MEXICO HEART PUMP DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. MEXICO HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 328. MEXICO HEART PUMP DEVICE MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 329. MEXICO HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. MEXICO HEART PUMP DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 331. MEXICO HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 332. MEXICO HEART PUMP DEVICE MARKET SIZE, BY DESTINATION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 333. BRAZIL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 334. BRAZIL HEART PUMP DEVICE MARKET SIZE, BY DEVICE CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 335. BRAZIL HEART PUMP DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2024 (USD MILLION)
  • TABLE 336. BRAZIL HEART PUMP DEVICE MARKET SIZE, BY VENT